Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.

Lerut, Jan;Lai, Quirino
(2023) Transplantation — Vol. 107, n° 7, p. 1434-1435 (2023)

Files

2023_Lerut_Transplantation_Ab.pdf
  • Open Access
  • Adobe PDF
  • 182.59 KB
Download
2023_Lerut_Transplantation.pdf
  • Restricted Access
  • Adobe PDF
  • 379.09 KB
Request a copy

Details

Authors
Abstract
Liver transplantation (LT) is the best curative therapy for patients with hepatocellular cancer (HCC) developed in a diseased liver. During the last 25 y, access to LT has been limited by using the very restrictive morphologic Milan (MC) or the University of California San Francisco criteria. More recently, these criteria have been extended without compromising oncologic outcomes, thanks to the dynamic biology and tumor morphology combination. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Lerut, J., & Lai, Q. (2023). Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Transplantation, 107(7), 1434-1435. https://doi.org/10.1097/TP.0000000000004488 (Original work published 2023)